Literature DB >> 35997945

Alcohol and Psoriasis for the Dermatologist: Know, Screen, Intervene.

Niamh Kearney1,2, Brian Kirby3,4,5.   

Abstract

Psoriasis patients are at increased risk of harmful alcohol use and alcohol dependency with many deleterious effects. Increasing alcohol use is associated with worsening psoriasis severity, is a risk factor for poor response to systemic treatments and may impact on comorbidities such as psoriatic arthritis, cardiovascular disease, cancer and liver disease. Harmful alcohol use and alcohol dependency can be defined by the updated ICD-11 coding system and screening can be completed using many tools including the Cut down, Annoyed, Guilty, Eye-Opener (CAGE), Alcohol Use Disorders Identification Test (AUDIT) and Michigan Alcohol Screening Test (MAST) questionnaires. Dermatologists may be able to complete brief interventions encouraging alcohol reduction in psoriasis patients. Psoriasis patients may respond to messages of gain with reduced psoriasis severity and loss with reduced cardiovascular risk. It is important for dermatologists to discuss alcohol with all psoriasis patients, to be aware of the impact of alcohol in psoriasis and to familiarise themselves with screening tools, brief intervention and local services available to patients who require specialist input for harmful alcohol use or alcohol dependency.
© 2022. The Author(s).

Entities:  

Mesh:

Year:  2022        PMID: 35997945      PMCID: PMC9576661          DOI: 10.1007/s40257-022-00713-z

Source DB:  PubMed          Journal:  Am J Clin Dermatol        ISSN: 1175-0561            Impact factor:   6.233


  54 in total

1.  The CAGE questionnaire for detection of alcoholism: a remarkably useful but simple tool.

Authors:  Charles P O'Brien
Journal:  JAMA       Date:  2008-11-05       Impact factor: 56.272

2.  Increased Prevalence of Alcohol Use Disorder (AUD) in Psoriasis and Dermatitis (Eczema).

Authors:  Gargi Taneja; Anindya Das; Naveen Kumar Kansal; Neirita Hazarika
Journal:  Skinmed       Date:  2021-04-01

Review 3.  Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with awareness and attention to comorbidities.

Authors:  Craig A Elmets; Craig L Leonardi; Dawn M R Davis; Joel M Gelfand; Jason Lichten; Nehal N Mehta; April W Armstrong; Cody Connor; Kelly M Cordoro; Boni E Elewski; Kenneth B Gordon; Alice B Gottlieb; Daniel H Kaplan; Arthur Kavanaugh; Dario Kivelevitch; Matthew Kiselica; Neil J Korman; Daniela Kroshinsky; Mark Lebwohl; Henry W Lim; Amy S Paller; Sylvia L Parra; Arun L Pathy; Elizabeth Farley Prater; Reena Rupani; Michael Siegel; Benjamin Stoff; Bruce E Strober; Emily B Wong; Jashin J Wu; Vidhya Hariharan; Alan Menter
Journal:  J Am Acad Dermatol       Date:  2019-02-13       Impact factor: 11.527

Review 4.  Alcohol consumption and risk of metabolic syndrome: a meta-analysis of prospective studies.

Authors:  Kan Sun; Meng Ren; Dan Liu; Chuan Wang; Chuan Yang; Li Yan
Journal:  Clin Nutr       Date:  2013-10-14       Impact factor: 7.324

5.  Prevalence of alexithymia in patients with psoriasis and its association with disease burden: a multicentre observational study.

Authors:  F Sampogna; L Puig; P Spuls; G Girolomoni; M A Radtke; B Kirby; M Brunori; P Bergmans; P Smirnov; J Rundle; F Lavie; C Paul
Journal:  Br J Dermatol       Date:  2017-04-10       Impact factor: 9.302

Review 6.  Integrating screening, brief intervention, and referral to treatment (SBIRT) into clinical practice settings: a brief review.

Authors:  Suneel M Agerwala; Elinore F McCance-Katz
Journal:  J Psychoactive Drugs       Date:  2012 Sep-Oct

7.  Risk of liver disease in patients with psoriasis, psoriatic arthritis, and rheumatoid arthritis receiving methotrexate: A population-based study.

Authors:  Joel M Gelfand; Joy Wan; He Zhang; Daniel B Shin; Alexis Ogdie; Maha N Syed; Alexander Egeberg
Journal:  J Am Acad Dermatol       Date:  2021-02-16       Impact factor: 11.527

Review 8.  Alcohol Consumption and the Risk of Incident Atrial Fibrillation: A Meta-Analysis.

Authors:  Georgios Giannopoulos; Ioannis Anagnostopoulos; Maria Kousta; Stavros Vergopoulos; Spyridon Deftereos; Vassilios Vassilikos
Journal:  Diagnostics (Basel)       Date:  2022-02-13

9.  Risk Factors for Diagnosis of Psoriatic Arthritis, Psoriasis, Rheumatoid Arthritis, and Ankylosing Spondylitis: A Set of Parallel Case-control Studies.

Authors:  Elana Meer; Telma Thrastardottir; Xingmei Wang; Maureen Dubreuil; Yong Chen; Joel M Gelfand; Thorvardur J Love; Alexis Ogdie
Journal:  J Rheumatol       Date:  2021-08-01       Impact factor: 5.346

Review 10.  Metabolic Syndrome and Psoriasis: Mechanisms and Future Directions.

Authors:  Yan Hao; Ya-Juan Zhu; Song Zou; Pei Zhou; Ya-Wen Hu; Qi-Xiang Zhao; Lin-Na Gu; Hao-Zhou Zhang; Zhen Wang; Jiong Li
Journal:  Front Immunol       Date:  2021-07-23       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.